Endpts.com

Endpts. With a focus on the science, people and money that drive the industry.

Today's Endpts.com headlines: Observe fresh posts and updates on Endpts. This site presents new content regularly: it has recently posted 100+ news and keeps going on, reaching about 294K users monthly. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Endpts

Subscribe to related news

Teva CEO Erez Vigodman Resigns
via nocamels

February 7, 2017 | Teva Pharmaceutical Industries Ltd. announced last night that CEO Erez Vigodman has resigned. He will be replaced as interim president and CEO by Dr. Yitzhak Peterburg, who has served as Chairman of the Teva Board of Directors since...
QRxPharma Issues Statement On Moxduo® Advisory Committee Meeting - MarketWatch
via forum.smarthealthshop

SYDNEY and BEDMINSTER, N.J., April 22, 2014 /PRNewswire/ -- QRxPharma (asx:QRX and OTCQX) announced today that the United States Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee has voted to recommend...
Teva Inks Biggest Deal in Israeli Pharmaceutical Industry’s History
via algemeiner

A Teva factory in Kfar Saba, Israel. The company finalized an acquisition for $40.5 billion. Photo: Wikimedia Commons. JNS.org – Israeli pharmaceutical giant Teva announced Tuesday that it has finalized its acquisition of Dublin-based Allergan’s Actavis...
Movement to impeach Obama snowballing
via nesaranews.blogspot

Sent: Tuesday, September 10, 2013 8:59 AM Subject: Fw: Obama to be impeached? Sent: Tuesday, September 10, 2013 7:39 AM Subject: Obama to be impeached? Email not displaying correctly? View it in your browser. Movement to impeach Obama snowballing...
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer
via investingnews

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) today announced that its Board of Directors has appointed Michael M. Goldberg, M.D. as President and Chief Executive Officer effective September 22, 2016. The Board of Directors has also appointed Eric...

Endpts.com popular pages

Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch

David Pyott has a new gig to add to his post-Allergan CV. Pyott and Takeda co-led a $13 million startup round for Bioniz, an Irvine, CA-based developer which just had ...
Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

Facing questions on patient deaths, Aurinia shares crater in wake of lupus study – ENDPOINTS NEWS

Aurinia Pharmaceuticals managed to kick up a brief spike in its share price this morning after releasing some upbeat numbers from a Phase IIb study of its lupus drug voclosporin. But it didn’t last lo...